Business Context and Reporting Period
This Form 8-K is a current report filed by Dataram Corporation (not U.S. Gold Corp. as indicated in metadata) on February 6, 2015, covering events occurring on February 4, 2015. The filing addresses corporate governance issues regarding NASDAQ listing compliance and the upcoming retirement of a senior executive.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes rather than financial performance.
Material Changes
- NASDAQ Non-Compliance: The Company received notice from NASDAQ that it no longer complies with Listing Rule 5605 regarding audit committee requirements. The committee currently has only two independent members (Michael E. Markulec and Richard D. Butler Jr.) instead of the required minimum of three.
- Executive Transition: David A. Moylan was appointed interim President and CEO and concurrently resigned from the Audit Committee, triggering the compliance issue.
- Executive Retirement: Jeffrey H. Duncan, Vice President of Manufacturing and Engineering since 1995, is scheduled to retire effective February 13, 2015.
Guidance, Outlook, and Risks
Compliance Cure Period: The Company has been granted a cure period to regain compliance with NASDAQ rules until the earlier of its next annual shareholders' meeting or January 22, 2016. If the next annual meeting occurs before July 21, 2015, compliance must be evidenced by that date.
Delisting Risk: Failure to regain compliance prior to the expiration of the cure period could result in written notification of delisting from The NASDAQ Stock Market. The Company retains the right to appeal such a determination.
Management Action: The Company has initiated a search for at least one additional independent director to restore full compliance with Rule 5605.
Compensation Arrangement: Mr. Duncan will receive his base salary for six months following his retirement under a Separation and Release of Claims Agreement.
Investor Verification Checklist
- Verify the timeline for the appointment of a new independent director to the Audit Committee.
- Confirm the date of the next annual shareholders' meeting to determine the exact deadline for NASDAQ compliance.
- Review the internal reassignment plan for the duties previously held by Jeffrey H. Duncan.
- Monitor future filings for any updates regarding the NASDAQ delisting risk or appeal proceedings.